Neura Health

Based in New York, US, and co-founded by Elizabeth Burstein (CEO) in 2020, Gezunt Inc. trading name under Neura Health operates as a health-tech company offering a virtual online neurology clinical services platform. In May 2023, the firm raised USD 8 million in seed funding co-led by investors Koch Disruptive Technologies and returning investor Norwest Venture Partners, with participation from other investors Next Play Ventures and Pear VC.   The company through its platform connects patients with board-certified neurologists and physician assistants trained at renowned medical institutions, to provide prompt and personalized treatment for neurological conditions.

Utilizing advanced telemedicine technology, Neura Health enables patients to schedule video visits with neurologists within days, along with a dedicated care team available 24/7 for unlimited online chat support and emotional guidance. Neura Health's services include personalized treatment plans, medication delivery, and referrals for further diagnostic tests when necessary, for conditions like headache and migraine, sleep disorder, seizures, concussion or TBI, stroke recovery, Tremor, etc. Neura Health generates revenue by offering its health-tech platform under different subscription plans such as a Monthly plan at USD 1 for a first-week trial, then USD 35 per month billed every month, along with a first video visit charge of USD 189, and follow-up video visits at USD 129 each, etc. The company plans to utilize the May 2023 funding for business expansion, product offerings, and go-to-market approach.